Wakamoto Pharmaceutical Co.,Ltd.
4512
Rank in Stocks
#21759
Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in... Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in the production and distribution of both prescription and over-the-counter pharmaceuticals across the country. Their diverse offerings include Strong Wakamoto, a widely recognized gastrointestinal aid formulated to enhance digestion, regulate intestinal health, and supplement nutrition. Additionally, the company provides AVANTBISE oral tablets, a dietary supplement designed to rebalance the oral microbiome, as well as various medicated toothpastes. Founded in 1929, the enterprise was initially known as Society for Nutrition and Raising Children Co., Ltd. before formally changing its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943.
Share Price
$1.82
Last synced: 2026-11-10
Market Cap
$63.05M
Change (1 day)
3.61%
Change (1 year)
-0.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Wakamoto Pharmaceutical Co.,Ltd. (4512)
Category
Healthcare
Operating Margin for Wakamoto Pharmaceutical Co.,Ltd. (4512)
Operating Margin as of November 2026 TTM: 2.58%
According to Wakamoto Pharmaceutical Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 2.58%. At the end of 2025 the company had an operating margin of -5.88%.
Operating Margin history for Wakamoto Pharmaceutical Co.,Ltd. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.58% | -143.88% |
| 2025 | -5.88% | 132.41% |
| 2024 | -2.53% | -255.21% |
| 2023 | 1.63% | -1,118.75% |
| 2022 | -0.16% | -98.12% |
| 2021 | -8.49% | -7.01% |
| 2020 | -9.13% | 150.82% |
| 2019 | -3.64% | 443.28% |
| 2018 | -0.67% | -182.72% |
| 2017 | 0.81% | 9.46% |
| 2016 | 0.74% | -23.71% |
| 2015 | 0.97% | -20.49% |
| 2014 | 1.22% | 480.95% |
| 2013 | 0.21% | -103.97% |
| 2012 | -5.29% | -32.27% |
| 2011 | -7.81% | 1,635.56% |
| 2010 | -0.45% | -122.28% |
| 2009 | 2.02% | -66.16% |
| 2008 | 5.97% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -92.48% |
DE
|
|
| 19.68% | -92.37% |
DE
|
|
| 13.26% | -94.86% |
JP
|
|
| 17.08% | -93.38% |
CH
|
|
| 14.92% | -94.22% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Wakamoto Pharmaceutical Co.,Ltd.'s operating margin
What is Wakamoto Pharmaceutical Co.,Ltd.'s operating margin?
Wakamoto Pharmaceutical Co.,Ltd.'s operating margin is 2.58%, as of Nov 2026.
What was Wakamoto Pharmaceutical Co.,Ltd.'s operating margin in 2025?
In 2025, Wakamoto Pharmaceutical Co.,Ltd.'s operating margin was -5.88%, compared with -2.53% in 2024.
How has Wakamoto Pharmaceutical Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Wakamoto Pharmaceutical Co.,Ltd.'s operating margin was highest in 2023 (1.63%) and lowest in 2020 (-9.13%).
How does Wakamoto Pharmaceutical Co.,Ltd.'s operating margin compare with similar companies?
Wakamoto Pharmaceutical Co.,Ltd.'s operating margin (2.58%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.